Cadonilimab in combination with chemotherapy for HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a cost-effectiveness analysis

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC12339465 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature